Latest Administration News

Mineral Commodities Limited and key subsidiaries have entered voluntary administration, with McGrathNicol appointed to explore sale or recapitalisation options. The Skaland Graphite mine operations in Norway remain unaffected, but shares are suspended pending creditor meetings.

EPX Limited has secured Wattwatchers Pty Limited through a Deed of Company Arrangement, backed by a $2.14 million placement and a Share Purchase Plan to raise additional funds. This strategic move enhances EPX’s energy monitoring capabilities and recurring revenue streams.

American West Metals is set to launch a major drilling campaign at its West Desert Project in Utah, aiming to expand its world-class indium resource and explore high-grade gallium mineralisation. This initiative aligns closely with the US government's renewed focus on securing domestic critical metals supply chains.

Assetora Limited has appointed external administrators following a contested debt claim by SILC, signaling a complex financial and legal standoff. The company disputes the debt but is prepared to pay to avoid further costs while continuing to challenge the claim.

Receivers and administrators have been appointed to 54 pharmacies within the Infinity Retail Pharmacy Group, catching Paragon Care off guard despite ongoing debt restructuring talks. The company pledges to support an orderly resolution to maximise creditor returns.

Lodestar Minerals has defined its first Exploration Target at the Neds Creek Gold Project in Western Australia, estimating up to 300,000 ounces of gold within an open-pit framework. The company plans a significant drilling campaign in early 2026 to validate and potentially upgrade this target to a JORC-compliant Mineral Resource.

Actinogen Medical has finalized enrollment and begun treatment of all 246 participants in its XanaMIA Phase 2b/3 Alzheimer’s trial, with topline results expected in November 2026. The oral drug Xanamem targets brain cortisol to potentially slow disease progression.

Buru Energy is actively pursuing funding for its 2026 drilling campaign to validate resources at the Rafael Gas Project, aiming for a Final Investment Decision in the second half of 2026 and first cashflow by 2028.

Telix Pharmaceuticals confirms completion of Part 1 enrolment in its ProstACT Phase 3 trial for prostate cancer, with safety data supporting progression to Part 2 and regulatory approvals secured across multiple countries.

Epsilon Healthcare reported a 19% revenue increase to $3.4 million for the half year ended June 2025, driven by new client wins and its pharmacy segment launch. However, net losses widened 44% to $2.07 million, reflecting administration and financing costs during its recovery phase.

Alara Resources and partners have completed their maiden drilling program at Oman’s Block 8, revealing encouraging copper and zinc mineralisation consistent with Volcanogenic Massive Sulphide deposits. The results validate the geological model and set the stage for further exploration.

AWAG has accelerated its growth trajectory by doubling its authorised representatives and increasing funds under management to $3.6 billion through strategic investments in Avalon Financial Services and SWR Chartered Accountants.